Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf (Lung-EPICLIN/G)

AstraZeneca

Status: Completed

Conditions: Non Small Cells Lung Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT01562665

NIS-OAE-XXX-2011/1

Details and patient eligibility

About

The overall aim of the study is:

To provide accurate and reliable information regarding NSCLC clinical management across MENA region in order to detect unmet medical needs of this disease in terms of:

• Patient and hospital characteristics.
• Diagnostic and treatment approaches: initial and subsequent.
• Follow-up patterns in clinical management.
• Outcomes: symptoms, death, functionality, quality of life.
• Use of resources and burden on patients and health care systems.

Full description

Epidemiological study to describe NSCLC clinical management patterns in MENA

Enrollment: 25 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women, attending the responsible department of treating this type of patients for the first time between November 1st, 2011 and August 30th, 2012 For PRO

• Sub-sample:

  • ability to read and write since they will be asked to participate in the PRO part of the study.

• Selection will not be based on the disease stage of each patient, in order to avoid a selection bias.

Exclusion criteria

• According to the study design there will not be any exclusion criteria in order to provide a high validity and to obtain the most accurate real daily practice information.

Trial design

25 participants in 2 patient groups

All Population

Sample of patients will be invited to complete Quality of Life